The temporary block of the deal that was first announced at the tail end of 2022 was ultimately enough to sink IQVIA and DeepIntent’s plans, according to DeepIntent CEO Chris Paquette.
Goldman Sachs closes $650M investment fund to spur life sciences innovation
The closing of Goldman Sachs’ West Street Life Sciences I finished well above its original target and represents one of the largest first-time private life sciences growth funds.
PerkinElmer buys Covaris to boost next-gen life sciences offerings
PerkinElmer announced it will acquire Covaris, a manufacturer of applications and reagents used in life science research, as part of its goal to expand its life sciences portfolio.
Rainbird taps Klick Health as North American life sciences partner